Cue Biopharma, Inc. CUE
NASDAQ · United States · Health Technology
$25.57+0.32 (+1.27%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -24.14 | -1.69 | -1,328.4% | $7.88M | +162.6% | -11.1%$31.08→$27.64 |
| Q1 2026 | 2026-05-14 | -1.08 | -3.30 | +67.3% | — | — | -21.9%$29.47→$23.01 |
| Q4 2025 | 2026-03-16 | 0.30 | -2.70 | +111.1% | — | — | -4.2%$8.52→$8.16 |
| Q3 2025 | 2025-11-12 | -2.10 | -2.55 | +17.6% | — | — | -9.2%$20.49→$18.60 |
| Q2 2025 | 2025-08-12 | -2.70 | -3.90 | +30.8% | — | — | — |
| Q1 2025 | 2025-05-12 | -5.10 | -4.60 | -10.9% | — | — | — |
| Q4 2024 | 2025-03-31 | -3.84 | -4.35 | +11.7% | — | — | — |
| Q3 2024 | 2024-11-14 | -5.13 | -5.70 | +10.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.